国际眼科杂志Issue(11)：2227-2230,4.DOI:10.3980/j.issn.1672-5123.2013.11.18
视网膜静脉阻塞引起黄斑水肿的药物治疗进展
Advance in pharmaco-therapy of macular edema in retinal vein occlusion
摘要
Abstract
Retinal vein occlusion ( RVO ) is the most common, vision-threatening, retinal vascular disease after diabetic retinopathy.RVO has characteristics of the retinal vein dilation and circuity, and retinal hemorrhage, edema and exudation along the vein. If edema occurs in macular area, it will lead to severe decreased central visual acuity. Though the clinical entity of RVO has been known for 100 years, the treatment remains unsatisfied.The advent of glucocorticoid and anti-vascular endothelial growth factor agents has made great progress in the treatment.The article illustrates the mechanism of macular oedema( MO) secondary to RVO. The pharmacological action and advancement of the drugs of glucocorticoid and anti-vascular endothelial growth factor agents are reviewed in this article.The prospects in the treatment of this disease are also mentioned.关键词
视网膜静脉阻塞/黄斑水肿的治疗/糖皮质激素/抗血管内皮生长因子药物/球内注射Key words
retinal vein occlusion/macular oedema treatment/glucocorticoid/anti -vascular endothelical growth factor/intracular injection引用本文复制引用
张璐,赵博军..视网膜静脉阻塞引起黄斑水肿的药物治疗进展[J].国际眼科杂志,2013,(11):2227-2230,4.基金项目
山东省自然科学基金 （）
